Cite
HARVARD Citation
Haddad, R. et al. (n.d.). 1117TiPIMvoke010: Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN). Annals of oncology. p. . [Online].